Eterna Therapeutics Inc (ERNA) Stock Price, Quote & News

Company Profile

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. Th...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 798 6700

Website: www.ernexatx.com

Address:

1035 Cambridge Street, Suite 18A, Cambridge, United States

frankyboyz May. 13 at 7:33 AM

Support and retweet: #frankysWL The one and only Franky’s Watchlist May. 13, 2026 Edition TAU - Trend Analytics classes starting soon in March. Come check this out: https://trendanalytics.com/tau “Afterhours Movers, where tomorrow’s runners are born.” ━━━━━━━━━━━━━━━━━━━━━ $OCG $ERNA $AEHL and few more... come read here https://x.com/frankyboyz/status/2054464621491204362 Franky

0 · Reply

polloboy May. 13 at 3:53 AM

$ERNA Why did this drop from the $30’s to sub $10’s back in early February?

0 · Reply

Longislandbull May. 13 at 3:03 AM

Premarket gameplan PAID for our members today $BZFD $WOK $TDIC $CREG $ERNA Don’t miss out on another hot small cap day tomorrow! Catch them first with us 👇 https://trifectatrading.tiiny.site/

1 · Reply

StockScanners May. 13 at 2:49 AM

$ERNA keep watch if this holds above 11.21

0 · Reply

HugeAckman May. 13 at 2:26 AM

$ERNA $GP $SYNX this member has some really good calls that have gone up more than twits alone could cause. You first say I like you a lot, then dump on them? I’m sure you meant no offense though.

0 · Reply

KeepGrinding May. 13 at 2:11 AM

$ERNA $IXHL $KOPN $OPEN $MBAI 🔥🚀📈💯 #1 He Hits Dingers!⬇️ https://youtu.be/InQ7MSZT194?si=9MW4OQKoBduk9X3_

0 · Reply

Stock_Catcher May. 13 at 2:04 AM

Wealthy Wednesday Watchlist Pt.4 $QCLS $IXHL $OPEN $ERNA $KOPN Tomorrow Might be ....

0 · Reply

Holten7575 May. 13 at 1:27 AM

$IFRX $ERNA our day is coming as well

1 · Reply

DayTrade_4Life May. 13 at 12:41 AM

Some stocks to Watch for 13 May: FCHL OCG WOK VELO TDIC $ERNA $BWEN $RXT Check out our link in profile to Learn while you Earn.

0 · Reply

cloudee1 May. 13 at 12:34 AM

$ERNA still showing over 900% for short interest on webull

0 · Reply

Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101

2026-05-07T21:58:10.000Z - 5 days ago

Ernexa Therapeutics initiated with a Buy at Brookline

2026-05-07T16:17:11.000Z - 5 days ago

3 Penny Stocks to Watch Now, 5/7/26

AHMA PMAX

2026-05-07T04:27:19.000Z - 6 days ago

Ernexa Therapeutics announces new ERNA-101 preclinical data

May 6, 2026, 8:33 AM EDT - 6 days ago

Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models

2026-04-30T19:19:12.000Z - 12 days ago

Ernexa Therapeutics announces 1-for-25 reverse stock split

Apr 30, 2026, 9:00 AM EDT - 12 days ago

Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split

Mar 31, 2026, 8:55 AM EDT - 6 weeks ago

Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026

2026-03-16T10:56:34.000Z - 2 months ago

Ernexa Therapeutics files $50M mixed securities shelf

Feb 20, 2026, 9:05 AM EST - 2 months ago

Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series

2026-02-06T14:30:30.000Z - 3 months ago

Ernexa Therapeutics prices 21M shares at 50c in public offering

Feb 6, 2026, 9:25 AM EST - 3 months ago

Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering

Feb 3, 2026, 8:45 AM EST - 3 months ago

Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA

2026-02-03T11:21:14.000Z - 3 months ago

Ernexa Therapeutics files to sell common stock, warrants, no amount given

2026-01-27T13:52:07.000Z - 3 months ago

Ernexa selected as company for JETRO Japan entry acceleration program

Jan 27, 2026, 8:45 AM EST - 3 months ago

Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program

2026-01-06T13:38:50.000Z - 4 months ago

Ernexa Therapeutics completes Pre-IND meeting with FDA

Jan 6, 2026, 8:15 AM EST - 4 months ago

Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer

2025-12-08T13:40:52.000Z - 5 months ago

Ernexa Therapeutics presents preclinical data at ASH meeting on ERNA-101

Dec 8, 2025, 8:30 AM EST - 5 months ago

Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer

Dec 3, 2025, 8:30 AM EST - 5 months ago

Ernexa Therapeutics Announces Oral Presentation at the 67th American Society of Hematology (ASH) Annual Meeting

2025-12-02T13:55:30.000Z - 5 months ago

Ernexa Therapeutics appoints Ira Winer to Scientific, Medical Advisory Board

Dec 2, 2025, 8:50 AM EST - 5 months ago

Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D.

Nov 11, 2025, 7:00 AM EST - 6 months ago

Ernexa Therapeutics to Present at Oxford Global's Cell 2025

2025-11-10T13:40:53.000Z - 6 months ago

Ernexa Therapeutics reports Q3 operating loss $2M vs $2.3M last year

Nov 10, 2025, 8:35 AM EST - 6 months ago

Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials

Nov 6, 2025, 9:15 AM EST - 6 months ago

Ernexa Therapeutics Showcases Strategic Partnership with Cellipont Bioservices to Advance Toward First-in-Human Trials on Virtual Investor “What This Means” Platform

2025-10-29T12:35:32.000Z - 6 months ago

Ernexa Therapeutics, Cellipont Bioservices enter collaboration

Oct 29, 2025, 8:33 AM EDT - 6 months ago

Cellipont Bioservices and Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership to Advance ERNA-101 Toward Clinical Trials in Ovarian Cancer

Oct 1, 2025, 8:30 AM EDT - 7 months ago

Ernexa Therapeutics to Deliver Company Presentation at the Annual Cell & Gene Meeting on the Mesa

Sep 29, 2025, 8:30 AM EDT - 8 months ago

Ernexa Therapeutics President & CEO Sanjeev Luther to Present on Expert Panel at 5th Annual iPSC Drug Development Summit

Sep 17, 2025, 8:30 AM EDT - 8 months ago

Ernexa Therapeutics to Present New Data in Oral Presentation at AACR Special Conference in Cancer Research

2025-09-10T12:35:19.000Z - 8 months ago

Ernexa Therapeutics reports 1H operational loss $5.4M vs $10.7M last year

Sep 10, 2025, 8:30 AM EDT - 8 months ago

Ernexa Therapeutics Provides Update on Operational Excellence and Performance

Sep 3, 2025, 9:30 AM EDT - 8 months ago

Ernexa Therapeutics Announces Presentation At The H.C. Wainwright 27th Annual Global Investment Conference

2025-07-09T12:40:48.000Z - 10 months ago

Ernexa Therapeutics regains compliance with Nasdaq listing rules

Jul 9, 2025, 8:30 AM EDT - 10 months ago

Ernexa Therapeutics Regains Compliance with Nasdaq Listing Requirements

Jun 25, 2025, 8:30 AM EDT - 11 months ago

Ernexa Therapeutics Expands Advisory Board to Form Integrated Scientific and Medical Advisory Board as it Prepares for Clinical Development

Jun 24, 2025, 8:30 AM EDT - 11 months ago

Ernexa Therapeutics Secures $6 Million in Second Closing Under Securities Purchase Agreement

Jun 10, 2025, 9:30 AM EDT - 1 year ago

Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split

May 28, 2025, 8:30 AM EDT - 1 year ago

Ernexa Therapeutics Announces New Data to be Presented at ASCO Annual Meeting 2025

May 14, 2025, 8:30 AM EDT - 1 year ago

Ernexa Therapeutics Establishes Texas Subsidiary to Support Continued Development of ERNA-101 and Future Clinical Operations

May 8, 2025, 8:30 AM EDT - 1 year ago

Ernexa Therapeutics Announces Participation in the D. Boral Capital Inaugural Global Conference

Apr 29, 2025, 8:30 AM EDT - 1 year ago

Ernexa Therapeutics Presented Promising Data on Innovative Cell Therapy Treatment at AACR Annual Meeting 2025

Apr 22, 2025, 8:30 AM EDT - 1 year ago

Ernexa Therapeutics Announces New Data to be Presented at AACR Annual Meeting 2025

Apr 3, 2025, 8:55 AM EDT - 1 year ago

Ernexa Therapeutics Closes New Funding Round

Feb 26, 2025, 8:30 AM EST - 1 year ago

Eterna Therapeutics Hosts Successful Inaugural Meeting with Newly Formed Scientific Advisory Board to Advance Cell Therapy Pipeline

Jan 14, 2025, 8:30 AM EST - 1 year ago

Eterna Therapeutics Announces Positive Preclinical Study Results on Lead Product ERNA-101 in Ovarian Cancer

Jan 9, 2025, 7:30 AM EST - 1 year ago

Eterna Therapeutics Announces Appointment of Dr. Elena Ratner to Board of Directors

Nov 14, 2024, 8:30 AM EST - 1 year ago

Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing

Oct 30, 2024, 8:30 AM EDT - 1 year ago

Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success

Oct 17, 2024, 8:00 AM EDT - 1 year ago

Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases

May 10, 2024, 8:00 AM EDT - 2 years ago

Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs

May 8, 2024, 9:31 AM EDT - 2 years ago

Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board

Feb 20, 2024, 8:30 AM EST - 2 years ago

Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors

Jan 3, 2024, 4:15 PM EST - 2 years ago

Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)

Dec 20, 2023, 4:15 PM EST - 2 years ago

Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer

Dec 14, 2023, 6:56 PM EST - 2 years ago

Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing

Nov 1, 2023, 8:30 AM EDT - 2 years ago

Eterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors

Sep 6, 2023, 8:00 AM EDT - 2 years ago

Eterna Therapeutics Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Lineage Cell Therapeutics

Sep 5, 2023, 8:30 AM EDT - 2 years ago

Eterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors

Jul 11, 2023, 8:30 AM EDT - 3 years ago

Eterna Therapeutics Appoints Biotech Industry Veterans Brant Binder and Richard Wagner, Ph.D. to Board of Directors

May 24, 2023, 8:30 AM EDT - 3 years ago

Eterna Therapeutics Appoints Megan Yung as Chief Strategy Officer, General Counsel

May 17, 2023, 8:30 AM EDT - 3 years ago

Eterna Therapeutics and Factor Bioscience Announce New Data on Multi-Cell-Type Therapeutic Approach at American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting

May 4, 2023, 8:30 AM EDT - 3 years ago

Eterna Therapeutics to Deliver Eight Presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting

frankyboyz May. 13 at 7:33 AM

0 · Reply

polloboy May. 13 at 3:53 AM

$ERNA Why did this drop from the $30’s to sub $10’s back in early February?

0 · Reply

Longislandbull May. 13 at 3:03 AM

Premarket gameplan PAID for our members today $BZFD $WOK $TDIC $CREG $ERNA Don’t miss out on another hot small cap day tomorrow! Catch them first with us 👇 https://trifectatrading.tiiny.site/

1 · Reply

StockScanners May. 13 at 2:49 AM

$ERNA keep watch if this holds above 11.21

0 · Reply

HugeAckman May. 13 at 2:26 AM

$ERNA $GP $SYNX this member has some really good calls that have gone up more than twits alone could cause. You first say I like you a lot, then dump on them? I’m sure you meant no offense though.

0 · Reply

KeepGrinding May. 13 at 2:11 AM

$ERNA $IXHL $KOPN $OPEN $MBAI 🔥🚀📈💯 #1 He Hits Dingers!⬇️ https://youtu.be/InQ7MSZT194?si=9MW4OQKoBduk9X3_

0 · Reply

Stock_Catcher May. 13 at 2:04 AM

Wealthy Wednesday Watchlist Pt.4 $QCLS $IXHL $OPEN $ERNA $KOPN Tomorrow Might be ....

0 · Reply

Holten7575 May. 13 at 1:27 AM

$IFRX $ERNA our day is coming as well

1 · Reply

DayTrade_4Life May. 13 at 12:41 AM

Some stocks to Watch for 13 May: FCHL OCG WOK VELO TDIC $ERNA $BWEN $RXT Check out our link in profile to Learn while you Earn.

0 · Reply

cloudee1 May. 13 at 12:34 AM

$ERNA still showing over 900% for short interest on webull

0 · Reply

Taylormax May. 13 at 12:30 AM

$ERNA It was a huge buy around 10 am today. Can you take a guess when this pumper will take profit?

0 · Reply

Mackey89 May. 13 at 12:27 AM

$ERNA potential to be a top gainer tomorrow 🔥 eyes on and low float

0 · Reply

SadyK189 May. 13 at 12:14 AM

Top Stocks to watch tomorrow 2 / 2: $AEHL $CPHI $ERNA $GAUZ $DGXX AEHL: Alerted at 1.44 for 1.85 - 2.05. Currently at 2.14. Still looking good on daily chart. Key support at 1.4 - 1.55 now. Next key level to test 2.65 - 2.85. DGXX: Initially alerted at 5.54. Currently at 9.05. Still looking good on daily chart. 7.35 - 7.70 is acting as key support zone. Next key level to test 10.1 - 10.55. CPHI: Getting up on 4hours chart. Key support at 0.65 - 0.69. Next key level to test 1.12 - 1.25. Currently at 0.9 ERNA: Initially alerted at 6.74. Currently at 12.9. Key support at 9.65 - 10.05. Next key level to test 14.8 - 15.40. GAUZ: Getting up on 4hours chart. 0.71 - 0.75 is acting as key support zone. Next key level to test 1.08 - 1.17. Currently at 0.89

0 · Reply

BearTamerTrading May. 13 at 12:06 AM

Top stocks alerted and traded today 👇🏾 $WOK $HTCO $ERNA $KOPN $DGXX Congratulations to all members, thank you for your trust and support, you deserve every win today. See attached and comments. Live trading stream replay (proof) 👇🏾 https://youtu.be/GYnZ7rIco1g

3 · Reply

polloboy May. 13 at 12:03 AM

$ERNA lol, so what’s the difference between after hours trading and overnight trading? At 5:00 it dropped about $1 instantly when the after hours window ended and the overnight window started.

0 · Reply

polloboy May. 12 at 11:50 PM

$ERNA It does look like it will gap up tomorrow morning.

0 · Reply

guccha May. 12 at 11:46 PM

$ERNA 👀

0 · Reply

jackedmund99 May. 12 at 11:38 PM

$ERNA Rules the 25-1 reverse split is a material event so—— Cooling-Off Periods: Rule 10b5-1 plans now require cooling-off periods before trading can start (later of 90 days or 2 business days after 10-K/10-Q filing, or 120 days

1 · Reply

jackedmund99 May. 12 at 11:35 PM

$ERNA insider are precluded from any insider transactions before and after a material event so I believe the shortest amount of time would be 10 biz days so there can’t be any selling now

0 · Reply

RhinoResurrected May. 12 at 11:35 PM

$ERNA lol

1 · Reply

MasterSquirt May. 12 at 11:34 PM

$ERNA It’s me and Rhino man against the world. Let’s get it bro

1 · Reply

RhinoResurrected May. 12 at 11:28 PM

$ERNA let's hope they fall under one of those 3. I dont want to be crying in my cheerios tomorrow morning.....

0 · Reply

Market Cap	1.43M
Revenue (ttm)	580,000.00
Net Income (ttm)	-44.54M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-7,679.31%
Debt to Equity Ratio	0.00

Volume	359,085
Avg Vol	12,707,749
Day's Range	N/A - N/A
Shares Out	5.41M
Stochastic %K	48%
Beta	4.47
Analysts	Hold
Price Target	N/A